Arca
Skip to content
Tools
Tools

Bupivacaine HCl 0.375% w/v and Lidocaine HCl 2% w/v Solution for Retrobulbar or…

Recall D-1514-2022, part of FDA recall event 90854. See Pine Pharmaceuticals's company page.

Pine Pharmaceuticals, LLC started this Class II drug recall on Jul 27, 2022 (voluntary: firm initiated); FDA lists it as terminated, terminated Oct 19, 2022.

  • Classification: Class II
  • Started: Jul 27, 2022
  • Status: Terminated

Why It Was Recalled

Class II

Lack of Assurance of Sterility

Record

Product
Bupivacaine HCl 0.375% w/v and Lidocaine HCl 2% w/v Solution for Retrobulbar or Peribulbar Injection; packaged in a) 10 mL prefilled syringe, Item# 803, barcode 6919408031; b) 5 mL prefilled syringe, Item# 933, barcode 6919409331, Rx only, Pine Pharmaceuticals, 355 Riverwalk Parkway, Tonawanda, NY 14150.
Quantity
a) 920 syringes; b) 3263 syringes
Lots and codes
Lot #s: a) 58366, exp. date 09/26/2022; 60247, exp. date 12/04/2022; b) 54825, exp. date 08/10/2022; 57583, exp. date 08/22/2022; 59343, exp. date 10/30/2022; 60355, exp. date 10/11/2022
Distribution
Product was distributed to direct accounts in AL, CA, NC and NY
Recalling firm
Pine Pharmaceuticals, LLC, Tonawanda, NY, United States
How the firm notified
Letter
FDA classified
Sep 15, 2022

Pine Pharmaceuticals, LLC's Other Recalls

Newest first, one product per recall event; search them all

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.